Kotaro Hashimoto

The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment

H. Sakurai, Y. Sotomaru, Takayuki Koyano, 2019, Scientific Reports.

Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease

N. Yanaka, Thanutchaporn Kumrungsee, T. Saliu, 2022, International journal of molecular sciences.

Comparative study on molecular mechanism of diabetic myopathy in two different types of streptozotocin-induced diabetic models.

N. Yanaka, Thanutchaporn Kumrungsee, T. Saliu, 2021, Life sciences.